Evidence map›Paper›PMID 35396500›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2022

Early life oxytocin treatment improves thermo-sensory reactivity and maternal behavior in neonates lacking the autism-associated gene Magel2.

Laura Caccialupi Da Prato, Ugo Zayan, Dina Abdallah, Vanessa Point, Fabienne Schaller, Emilie Pallesi-Pocachard, Aurélie Montheil, Stéphane Canaan, Jean-Luc Gaiarsa, Françoise Muscatelli and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. MAGEL2 (patho-)physiology and Schaaf-Yang syndrome.Developmental medicine and child neurology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Modulation of the thermosensory system by oxytocin.Frontiers in molecular neuroscience · 2022
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Laura Caccialupi Da PratoAix Marseille Univ, INSERM, INMED, Marseille, France.
Ugo ZayanAix Marseille Univ, INSERM, INMED, Marseille, France.
Dina AbdallahAix Marseille Univ, INSERM, INMED, Marseille, France.
Vanessa PointAix-Marseille Univ, CNRS, LISM, IMM, Marseille, France.
Fabienne SchallerAix Marseille Univ, INSERM, INMED, Marseille, France.
Emilie Pallesi-PocachardAix Marseille Univ, INSERM, INMED, Marseille, France.
Aurélie MontheilAix Marseille Univ, INSERM, INMED, Marseille, France.
Stéphane CanaanAix-Marseille Univ, CNRS, LISM, IMM, Marseille, France.ORCID http://orcid.org/0000-0001-7478-300X
Jean-Luc GaiarsaAix Marseille Univ, INSERM, INMED, Marseille, France.
Françoise MuscatelliAix Marseille Univ, INSERM, INMED, Marseille, France.
Valéry MatarazzoAix Marseille Univ, INSERM, INMED, Marseille, France. valery.matarazzo@inserm.fr.ORCID http://orcid.org/0000-0002-0833-203X
Inserm · FRCentre National de la Recherche Scientifique · FRJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atypical responses to sensory stimuli are considered as a core aspect and early life marker of autism spectrum disorders (ASD). Although recent findings performed in mouse ASD genetic models report sensory deficits, these were explored exclusively during juvenile or adult period. Whether sensory dysfunctions might be present at the early life stage and rescued by therapeutic strategy are fairly uninvestigated. Here we found that under cool environment neonatal mice lacking the autism-associated gene Magel2 present pup calls hypo-reactivity and are retrieved with delay by their wild-type dam. This neonatal atypical sensory reactivity to cool stimuli was not associated with autonomic thermoregulatory alteration but with a deficit of the oxytocinergic system. Indeed, we show in control neonates that pharmacogenetic inactivation of hypothalamic oxytocin neurons mimicked atypical thermosensory reactivity found in Magel2 mutants. Furthermore, pharmacological intranasal administration of oxytocin to Magel2 neonates was able to rescue both the atypical thermosensory response and the maternal pup retrieval. This preclinical study establishes for the first-time early life impairments in thermosensory integration and suggest a therapeutic potential benefit of intranasal oxytocin treatment on neonatal atypical sensory reactivity for autism.

Indexed as

Autistic DisorderHypesthesiaMaternal BehaviorOxytocinProteinsAdministration, IntranasalAge FactorsAnimalsAntigens, NeoplasmAutism Spectrum DisorderCentral Nervous System AgentsFemaleHypothalamusIntracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMiceAntigens, NeoplasmCentral Nervous System AgentsIntracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMagel2 protein, mouseOxytocinProteins

Identifiers

PMID35396500
PMCPMC9485246
OpenAlexW4223437114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.